AccessPak for HIV PEP Expanded with Kaletra and Ramucirumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Ranexa
- AccessPak for HIV PEP Expanded with Kaletra-Ranibizumab
- AccessPak for HIV PEP Expanded with Kaletra-Ranibizumab Intraocular
- AccessPak for HIV PEP Expanded with Kaletra-Ranibizumab ophthalmic
- AccessPak for HIV PEP Expanded with Kaletra-Ranitidine
- AccessPak for HIV PEP Expanded with Kaletra-Ranitidine Capsule
- Ramucirumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Ramucirumab Intravenous-Accolate
- Ramucirumab Intravenous-Accretropin
- Ramucirumab Intravenous-Accucaine
- Ramucirumab Intravenous-AccuHist Drops
- Ramucirumab Intravenous-AccuHist PDX Drops